Ceregate receives financing

Following a breakthrough in the clinical development of brain stimulation, Ceregate can attract new investors. Nothing is known about the amount of the investment.
Ceregate's current round of funding is led by new investors 468 Capital and Re.mind Capital. This means the startup has investors on board who are experienced in deep technology and mental health. Also participating in the funding round were existing investors TruVenturo, Heal Capital and High-Tech Gründerfonds.
The additional capital will be used to expand the team and further develop the platform. "We are very excited because this means that several applications of our technology that can provide real clinical solutions for patients are only 1-2 years away," said founder and CEO Bálint Várkuti.
The startup has developed a computer-brain interface platform that can relay information to the human brain and thus be used for neuromodulation therapy. The treatment is intended to help patients with neurological or sensory deficits. Ceregate's goal is to increase patients' independence and improve their quality of life.

Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingRelated companies
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?